Publications by authors named "Eric J Small"

280 Publications

Examining reporting and representation of patients with cancer in COVID-19 clinical trials.

Cancer Rep (Hoboken) 2021 Feb 23:e1355. Epub 2021 Feb 23.

Department of Medicine, Division of Hematology/Oncology, University of California San Francisco, San Francisco, California, USA.

View Article and Find Full Text PDF
February 2021

Does the COVID-19 outbreak identify a broader need for an urgent transformation of cancer clinical trials research?

Contemp Clin Trials 2020 05 6;92:105997. Epub 2020 Apr 6.

Department of Medicine, Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.

View Article and Find Full Text PDF
May 2020

Relationship Between Metastasis-free Survival and Overall Survival in Patients With Nonmetastatic Castration-resistant Prostate Cancer.

Clin Genitourin Cancer 2020 04 6;18(2):e180-e189. Epub 2019 Nov 6.

Division of Hematology and Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA.

View Article and Find Full Text PDF
April 2020

Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced Prostate Cancer.

Eur Urol 2020 03 20;77(3):333-341. Epub 2019 Oct 20.

Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.

View Article and Find Full Text PDF
March 2020

Treatment of advanced renal cell carcinoma patients with cabozantinib, an oral multityrosine kinase inhibitor of MET, AXL and VEGF receptors.

Future Oncol 2019 Jul 11;15(20):2337-2348. Epub 2019 Jun 11.

Department of Medicine, Division of Hematology/Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94143, USA.

View Article and Find Full Text PDF
July 2019

Germline and Somatic Mutations in Prostate Cancer for the Clinician.

J Natl Compr Canc Netw 2019 05;17(5):515-521

Division of Medical Oncology, University of Washington, and.

View Article and Find Full Text PDF
May 2019

Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC).

Prostate Cancer Prostatic Dis 2020 03 3;23(1):66-73. Epub 2019 May 3.

Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA.

View Article and Find Full Text PDF
March 2020